Independent Student Newspaper for the University of Texas at San Antonio

The Paisano

Independent Student Newspaper for the University of Texas at San Antonio

The Paisano

Independent Student Newspaper for the University of Texas at San Antonio

The Paisano

UTSA expands on dopamine research


Scientists at UTSA have recently uncovered a new relationship between the psychostimulant, cocaine and dopamine responses in the brain.

This new information, which was published in the most recent issue of the Journal of Neuroscience, sheds light into how the brain reacts when there is added efforts into receiving a drug reward.

Matt Wanat, an assistant professor of neuroscience at UTSA who published the article, believes that learning how the brain reacts to food rewards versus drug rewards is an important step in understanding drug addiction. Wanat studies the neurobiology of motivated behaviors, specifically, dopamine responses in the brain.

“The brain is a cluster of cells,” Wanat said.

Dopamine starts with the brain. These cells are constantly working and communicating with one another. The way they communicate is through chemicals called neurotransmitters.

Neurotransmitters are chemicals such as serotonin, dopamine and endorphin that can be released by the brain and act on other cells. These releases create a ripple effect throughout the brain which can stimulate actions or inhibit responses to certain outside stimuli.

“I hate to say that dopamine just does one thing,” Wanat said. “It’s not like dopamine equals the pleasure center. It’s involved with a large number of things. It’s important for natural learning, movement, it’s important in motivation. It’s a modulator.”

Dopamine responses in the brain are altered with drug addiction. Professor Wanat and head researcher Idaira Oliva’s experiment measured dopamine responses in rats that were trained to work for a drug reward. The experiment used voltammetry to measure chemical responses in the brain.

“If we give a food pellet to an animal we can see there is a nice rise of dopamine to that food pellet. If the animal likens a cocaine infusion we can see there is a nice rise of dopamine to that,” Wanat said.

The animals used a basic task – a lever press – to retrieve the reward.

“To look at how much effort an animal is willing to do what you can do is have an animal press once to get a food pellet, well the next time you’re going to have to press two times, the next time after that you’re going to have to press five times, then you’re going to have to press ten times, and then you’re going to have to press forty times,” Wanat said. “And you keep going up and up and up to a point where the animal says, ‘F*** it. I’m done,’ and that’s a very powerful way to get a measure of motivation. You can see how the dopamine signals change to these rewards as you change the cost.”

The results showed that there was a disconnect between the dopamine response in the brain when given drug rewards versus food rewards. In other words a larger dopamine response was given when working for a food reward than working for a drug reward.

These results give insight into how dopamine works in the body. Dopamine research is important for learning more about drug addiction and processes that might aid in research for illnesses associated with dopamine such as Parkinson’s disease.

Parkinson’s disease affects dopamine production. People who suffer from Parkinson’s have 85 to 90 percent decrease in the amount of dopamine in their body which inhibits their movement. This research could lead to a better understanding of dopamine that could one day lead to a cure or a better treatment for symptoms of Parkinson’s.

People who suffer from drug addiction have to overcome greater costs to obtain drugs.

“Drug addiction is a brain disease. It’s not just one part of the brain that’s misfiring, or not acting appropriately. That part of the brain talks to another part that talks to another part… that elicits change all throughout,” Wanat said.

Understanding how the brain reacts to drugs when compared to food gives researchers a glimpse into how the brain functions when working for rewards. Currently there is no FDA approved treatment for psychostimulant addiction. Wanat hopes that his research will help scientists uncover more about addiction and treatments.

More to Discover